Blog

Applications of proteomics in cancer – Proteomic analyses can reveal new breast cancer subtypes

The identification of new breast cancer subtypes based on proteomics may guide new treatment modalities and lead to better health outcomes.

Applications of proteomics in cancer – Identifying drivers and therapeutic opportunities in colon cancer

Colon cancer causes tens of thousands of deaths each year in the US alone. Learn how proteomics can help fight this devastating disease.

Applications of proteomics in cancer – Proteomics reveals inner workings of head and neck squamous cell carcinoma (HNSCC)

Better characterizing subtypes of HNSCC could lead to more personalized treatments for the disease.

Applications of proteomics in cancer – Multiomic study highlights the value of the proteome for prostate cancer prognoses

Pairing proteomic analysis with epigenetic and transcriptomic data could soon yield more informative prostate cancer prognoses.

Applications of proteomics in cancer – Identifying potential biomarkers and therapeutic targets in pancreatic ductal adenocarcinoma

A multiomics approach better identifies biomarkers and therapeutic targets in pancreatic ductal adenocarcinoma.

Applications of proteomics in cancer – Revealing molecular mechanisms of the epithelial to mesenchymal transition

Multiomic analyses empower researchers to uncover the intricate molecular mechanisms underlying the epithelial to mesenchymal transition.

Applications of proteomics in cancer – Insights from a multiomic analysis of lung adenocarcinoma

Gillette et al. identify potentially druggable pathways, determinants of immune cell invasion, and multiomic connections in lung cancer.

Applications of proteomics in cancer – assessing the potential of PROTACs

Learn how PROTACs enable researchers to exquisitely target cancer proteins for degradation and may make effective therapeutics.

Applications of proteomics in cancer – Round up

Proteomics provides deep, actionable insights into the mechanisms underlying cancer and can accelerate biomarker and drug development.